Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 7801–7820 of 17,529 recalls

January 2, 2019· Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

Recalled Item: Vitamin B12 liquid 1000mcg/ml

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 2, 2019· Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

Recalled Item: Glutathione liquid

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 2, 2019· Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

Recalled Item: Lidocaine/Epinepherine liquid 1%/ 1:1000

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 2, 2019· Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

Recalled Item: Epinephrine liquid 1:1000

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 2, 2019· Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

Recalled Item: Cyclosporin liquid 1%

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 2, 2019· Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

Recalled Item: Cyclosporin liquid 0.5%

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan Tablets USP 160 mg

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan Tablets USP 40 mg

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Amlodipine and Valsartan Tablets USP 10mg/160mg

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan Tablets USP 320 mg

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan Tablets USP 80 mg

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan tablets USP 320 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Amlodipine and Valsartan Tablets USP 10 mg/320 mg. 30-count bottles

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan and Hydrochlorothiazide tablets USP 160 mg/25 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan and Hydrochlorothiazide tablets USP 160mg/12.5 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Amlodipine and Valsartan Tablets USP 5 mg/320 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan and Hydrochlorothiazide tablets USP 320 mg/25 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan and Hydrochlorothiazide tablets USP 320mg/12.5 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Amlodipine and Valsartan Tablets USP 5 mg/160 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund